Notícias e Atualizações de Zeling

Chengdu Zeling Biomedical Technology patents new NLRP3 inflammasome inhibitors

Chengdu Zeling Biomedical Technology Co. Ltd. has disclosed NLRP3 inflammasome inhibitors reported t...

Oct 16, 2024 • BioWorld

New RIPK2 inhibitors disclosed in Chengdu Zeling Biomedical Technology patent

Chengdu Zeling Biomedical Technology Co. Ltd. has divulged receptor-interacting serine/threonine-pro...

May 22, 2025 • BioWorld

ZeLing Li

Zeling Li is a qualified practising lawyer in China, and has previously worked for the Judicial Bure...

May 03, 2019 • Business News

Chengdu Zeling Biomedical Technology patents NLRP3 inflammasome inhibitors

Chengdu Zeling Biomedical Technology Co. Ltd. has identified triazine compounds acting as NLRP3 infl...

Oct 09, 2024 • BioWorld

Chengdu Zeling Biomedical Technology describes new NLRP3 inflammasome inhibitors

Chengdu Zeling Biomedical Technology Co. Ltd. has identified bridged pyridazine compounds acting as ...

Jun 19, 2024 • BioWorld

People In Business: Dr. Zeling Chau of Baystate Health

PALMER/WARE - Baystate Health Eastern Region is pleased to announce the addition of Dr. Zeling Chau,...

Oct 13, 2016 • MassLive

Chengdu Zeling Biomedical Technology describes new PARP-1 inhibitors

Chengdu Zeling Biomedical Technology Co. Ltd. has identified poly (ADP-ribose) polymerase 1 (PARP-1;...

May 20, 2024 • BioWorld

Chengdu Zeling Biomedical Technology discovers new PARP-1 inhibitors

Chengdu Zeling Biomedical Technology Co. Ltd. has described poly (ADP-ribose) polymerase 1 (PARP-1; ...

May 19, 2025 • BioWorld

New NLRP3 inflammasome inhibitors described in Chengdu Zeling Biomedical patent

Chengdu Zeling Biomedical Technology Co. Ltd. has identified compounds acting as NLRP3 inflammasome ...

Jan 08, 2025 • BioWorld